Isabelle Mingam

Isabelle joined UCB in 2015, where she worked in the global regulatory affairs CMC team on biologics, leading large variations such as new drug substance manufacturing site, extending shelf life and specification and registering new device presentations. In 2019, she specialized in global regulatory affairs for medical devices, where she embraced the challenges related to Medical Devices Regulation implementation both for new products and life cycle management. More recently, she is also gaining experience in in-vitro diagnostics and companion diagnostics topics. Prior to joining UCB, Isabelle gained 10+ years experience in regulatory affairs, specialized in cell-based therapies and human tissue engineered products. She enjoys being part of path blazing teams, paving the way into changing regulatory and technical landscapes.